Hold Dr. Reddy's Laboratories; target of Rs 2620: Edelweiss

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Edelweiss' research report on Dr. Reddy's Laboratories

Dr Reddy’s (DRRD) faces a number of challenges ahead. Not only has the near term outlook turned negative owing to recent developments, the long term outlook remains uncertain.

Outlook

As per our discussions with other filers, a number of developments need to align for successful monetization of gCopaxone and gNuvaring (26% of FY19E EPS). We cut FY18E and FY19E EPS 22% and 17%, respectively. Maintain ‘HOLD’ with a target price of INR 2,620 (18x FY19E EPS).

For all recommendations, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More